These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12592221)

  • 1. Prognostic factors relating to esophageal cancer.
    Butsch J; Christein JD; Millikan K
    Minerva Chir; 2002 Dec; 57(6):789-94. PubMed ID: 12592221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.
    Rizk N; Venkatraman E; Park B; Flores R; Bains MS; Rusch V;
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1374-81. PubMed ID: 17140960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
    Joshi MB; Shirota Y; Danenberg KD; Conlon DH; Salonga DS; Herndon JE; Danenberg PV; Harpole DH
    Clin Cancer Res; 2005 Mar; 11(6):2215-21. PubMed ID: 15788669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
    Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
    J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
    J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in esophageal cancer.
    Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Ono H
    Hepatogastroenterology; 2004; 51(57):736-40. PubMed ID: 15143904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Richel DJ; Offerhaus GJ; van Lanschot JJ
    Ann Surg Oncol; 2007 Feb; 14(2):977-91. PubMed ID: 17122988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing an appropriate staging system for esophageal carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
    Liu XY; Chen G; Wang Z; Liu FY
    Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
    Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
    Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.